In particular, manuscripts did not fulfilling the eligibility criteria, because they were out of topic (focusing on general low-grade tumor of low-grade CD34+, three papers), not focusing on clinical characteristics (genomic or biological analysis, two papers), and four papers were excluded for insufficient detail of case analysis and finding (four papers). Here, CD34 is linked to neoplasm.